Gabelli & Co Investment Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-96,250	Closed	-$1.78M	–	294
2023 Q3	$1.78M	Buy	+96,250	New	+$1.09M	0.29%	60

Gabelli & Co Investment Advisers's ICPT Position: Q4 2023 in Review

Gabelli & Co Investment Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 96,250 shares — an estimated $1.78M sold.

Gabelli & Co Investment Advisers first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $1.78M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Gabelli & Co Investment Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 96,250 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.78M.
Gabelli & Co Investment Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Intercept Pharmaceuticals, Inc. position peaked at $1.78M in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.